Lineage Cell Therapeutics, Inc.

NYSEAM:LCTX 株式レポート

時価総額:US$154.1m

Lineage Cell Therapeutics 配当金

配当金 基準チェック /06

Lineage Cell Therapeutics does not have a record of paying a dividend.

主要情報

n/a

配当利回り

-9.8%

バイバック利回り

総株主利回り-9.8%
将来の配当利回りn/a
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当金アップデート

更新なし

Recent updates

What Type Of Shareholders Own The Most Number of Lineage Cell Therapeutics, Inc. (NYSEMKT:LCTX) Shares?

Feb 17
What Type Of Shareholders Own The Most Number of Lineage Cell Therapeutics, Inc. (NYSEMKT:LCTX) Shares?

If You Had Bought Lineage Cell Therapeutics (NYSEMKT:LCTX) Stock A Year Ago, You Could Pocket A 129% Gain Today

Dec 26
If You Had Bought Lineage Cell Therapeutics (NYSEMKT:LCTX) Stock A Year Ago, You Could Pocket A 129% Gain Today

決済の安定と成長

配当データの取得

安定した配当: Insufficient data to determine if LCTX's dividends per share have been stable in the past.

増加する配当: Insufficient data to determine if LCTX's dividend payments have been increasing.


配当利回り対市場

Lineage Cell Therapeutics 配当利回り対市場
LCTX 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (LCTX)n/a
市場下位25% (US)1.5%
市場トップ25% (US)4.5%
業界平均 (Biotechs)2.2%
アナリスト予想 (LCTX) (最長3年)n/a

注目すべき配当: Unable to evaluate LCTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

高配当: Unable to evaluate LCTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


株主への利益配当

収益カバレッジ: Insufficient data to calculate LCTX's payout ratio to determine if its dividend payments are covered by earnings.


株主配当金

キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as LCTX has not reported any payouts.


高配当企業の発掘